Two case reports: clinical experience with fixed combinations of indapamide/perindopril and amlodipine/perindopril in patients with arterial hypertension during the COVID-19 pandemic

Two case reports: clinical experience with fixed combinations of indapamide/perindopril and amlodipine/perindopril in patients with arterial hypertension during the COVID-19 pandemic

The article, using the example of two clinical cases, discusses the severity of the course of COVID-19 depending on the presence of cardiovascular diseases and the effectiveness of their treatment. Randomized clinical trials and meta-analyses of the coronavirus infection indicate a greater likelihoo...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. Ia. Tazina, I. A. Belyaev, T. A. Fedorova, N. A. Semenenko, S. A. Tazin
Format:	Article
Language:	Russian
Published:	InterMedservice 2022-05-01
Series:	Евразийский Кардиологический Журнал
Subjects:	psoriasis cardiovascular risk cardiovascular disease myocardial infarction stroke hypertension case report
Online Access:	https://www.heartj.asia/jour/article/view/6329
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiovascular diseases in patients with psoriasis in clinical practice: case report. Eurasian heart journal
by: O. A. Kuzmina, et al.
Published: (2022-03-01)

Triple fixed-dose combination of amlodipine, indapamide and perindopril for hypertension in patients with stable coronary artery disease and abdominal obesity
by: E. A. Polyakova, et al.
Published: (2024-02-01)

Clinical effectiveness of amlodipine/indapamide/perindopril fixed-dose combination in patients with metabolic disorders: results of post hoc analyzes of the TRICOLOR study
by: Yu. A. Karpov, et al.
Published: (2024-08-01)

EFFECTIVENESS OF PERINDOPRIL AND AMLODIPINE COMBINATION IN HYPERTENSIVES WITH COPD
by: O. N. Kryuchkova, et al.
Published: (2014-11-01)

Single-pill combination of indapamide and perindopril: potential of practical application
by: A. M. Kochergina, et al.
Published: (2024-04-01)

Perindopril and indapamide combination effects on circadian blood pressure profile and cerebral hemodynamics in patients with arterial hypertension and stroke
by: N. P. Shilkina, et al.
Published: (2007-06-01)

The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age
by: S. A. Shalnova, et al.
Published: (2024-06-01)

Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril
by: I. T. Murkamilov
Published: (2021-01-01)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Fixed dose combination of perindopril with indapamide in primary prevention of cerebrovascular complications among patients with metabolic syndrome and arterial hypertension
by: V. B. Mychka, et al.
Published: (2006-02-01)

Silent periprocedural myocardial infarction during non-cardiac surgery: a case report
by: E. V. Ivanova, et al.
Published: (2025-03-01)

South African hypertension society guidelines 2006
by: Yosuf Veriava
Published: (2007-03-01)

Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety
by: Ansel Shao Pin Tang, et al.
Published: (2025-07-01)

Comparative study of perindopril and perindopril metabolite pharmacokinetics using the HPLC/MS method
by: L. M. Krasnykh, et al.
Published: (2018-02-01)

Effectiveness of the fixed-dose combination therapy with perindopril and amlodipine in coronary heart disease patients after coronary artery bypass graft surgery
by: B. G. Iskenderov, et al.
Published: (2011-12-01)

New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
by: Yu. A. Karpov, et al.
Published: (2023-11-01)

The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases"
by: M. V. Zhuravleva, et al.
Published: (2022-03-01)

The impact of sleep disorders on the course of hypertension
by: A. V. Budnevsky, et al.
Published: (2021-06-01)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015-09-01)

Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
by: M. V. Leonova
Published: (1970-01-01)

THE PATTERN OF CARDIOVASCULAR COMORBIDITY IN PATIENTS WITH SEVERE FORMS OF PSORIASIS: DATA OF RETROSPECTIVE ANALYSIS OF A HOSPITAL COHORT
by: N. V. Batkaeva, et al.
Published: (2017-10-01)

ANALYSIS OF CORRELATION BETWEEN IL 6 GENE POLYMORPHISM (-174 G /C) AND CLASSIC RISK FACTORS IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTIONS
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

The genomic bases of atrial fibrillation in an Ecuadorian patient: a case report
by: Rafael Tamayo-Trujillo, et al.
Published: (2025-06-01)

THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM
by: I. G. Fomina, et al.
Published: (2016-01-01)

PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY
by: O. V. Dralova, et al.
Published: (2016-01-01)

Particularities of the course and treatment of non-ST elevation acute myocardial infarction: data from the REGION-IM registry
by: S. A. Boytsov, et al.
Published: (2024-05-01)

Identification of c.683_684insCTGCAAGGACAAATCTGACGA pathogenic variant of the low-density lipoprotein receptor gene in a patient with familial hypercholesterolemia: a case report
by: V. A. Korneva, et al.
Published: (2023-09-01)

Cardiovascular risk factors, clinical manifestations and management of myocardial infarction in elderly and longliving patients depending on geriatric status
by: S. V. Malchikova, et al.
Published: (2023-03-01)

VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL
by: Yu. N. Belenkov, et al.
Published: (2012-06-01)

THE PREDICTORS OF PNEUMONIA IN PATIENTS WITH ACUTE VASCULAR DISEASES
by: D. V. Odintsova, et al.
Published: (2017-03-01)

Embolic myocardial infarction associated with patent foramen ovale: a case series
by: A. M. Pivtsova, et al.
Published: (2023-02-01)

Predictive value of growth differentiation factor-15 in patients with myocardial infarction
by: A. A. Sabirzyanova, et al.
Published: (2021-03-01)

INTERRELATION OF TRANSCUTANEOUS CORONARY INTERVENTIONS FOR ACUTE FORMS OF CORONARY HEART DISEASE AND MORTALITY PARAMETERS IN TYUMEN REGION INHABITANTS
by: V. A. Kuznetsov, et al.
Published: (2014-06-01)

Unusual Syncope due to Intravascular Leiomyomatosis With Intracardiac Extension: A Case Report and Focused Literature Review
by: Ricardo Bohorquez Rodriguez, et al.
Published: (2025-08-01)

Impact of smoking cessation on cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries
by: Side Gao, et al.
Published: (2025-09-01)

Takeda G protein–coupled receptor 5 (TGR5): an attractive therapeutic target for aging-related cardiovascular diseases
by: Yufeng He, et al.
Published: (2025-03-01)

Cardiovascular risk in patients with a relationship with oxidative stress and dyslipidemia
by: Karanikolic Vesna, et al.
Published: (2025-01-01)

Acute nitroglycerin test for predicting perindopril therapy effectiveness in patients with coronary heart disease and chronic heart failure
by: I. G. Fomina, et al.
Published: (2005-12-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

Latent Cytomegalovirus Infection Is Associated With Impaired Left Ventricular Function After ST‐Segment–Elevation Myocardial Infarction
by: Luke Spray, et al.
Published: (2025-08-01)